Document is current
Any future updates will be listed below
-
Authors
Li, Dan
He, Wu
Yu, Bo
Wang, Dao Wen
Ni, Li
-
Clinical Trials BETA
Clinical trials referenced in this document:
chictr2000031587 at Chinese Clinical Trial Registrynct05615792 at ClinicalTrials.govDocuments that mention this clinical trial
NT-proBNP ratio is a potential predictor for COVID-19 outcomes in adult Chinese patients: a retrospective study
https://doi.org/10.1038/s41598-024-56329-2
Documents that mention this clinical trial
NT-proBNP ratio is a potential predictor for COVID-19 outcomes in adult Chinese patients: a retrospective study
https://doi.org/10.1038/s41598-024-56329-2
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82100526)
National Natural Science Foundation of China (No. 82330010)
National Natural Science Foundation of China (No. 82241034)
National Natural Science Foundation of China (82070354)
National Natural Science Foundation of China (81470519)
- License Information
-
More Information
Article History
Received: 26 October 2023
Accepted: 5 March 2024
First Online: 11 March 2024
Competing interests
: The authors declare no competing interests.
